<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns='http://www.w3.org/1999/xhtml' xml:lang='en' lang='en'><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"></meta>
<title>fieldNames.html</title>



</head>
<body><table border="1">
<tr>
<td bgcolor="#ffdc98">start</td><td bgcolor="#ffdc98">width</td><td bgcolor="#ffdc98">SAS</td><td bgcolor="#ffdc98">SEERaBomb</td><td bgcolor="#ffdc98">desc</td></tr>
<tr>
<td>  1</td><td> 8</td><td>CASENUM</td><td>casenum</td><td>Patient ID</td></tr>
<tr>
<td>  9</td><td>10</td><td>REG</td><td>reg</td><td>SEER registry</td></tr>
<tr>
<td> 19</td><td> 1</td><td>MAR_STAT</td><td>marstat</td><td>Marital status at diagnosis</td></tr>
<tr>
<td> 20</td><td> 2</td><td>RACE</td><td>race</td><td>Race/ethnicity</td></tr>
<tr>
<td> 22</td><td> 1</td><td>ORIGIN</td><td>origin</td><td>Spanish surname or origin</td></tr>
<tr>
<td> 23</td><td> 1</td><td>NHIA</td><td>nhia</td><td>NHIA Derived Hisp Origin</td></tr>
<tr>
<td> 24</td><td> 1</td><td>SEX</td><td>sex</td><td>Sex</td></tr>
<tr>
<td> 25</td><td> 3</td><td>AGE_DX</td><td>agedx</td><td>Age at diagnosis</td></tr>
<tr>
<td> 28</td><td> 4</td><td>YR_BRTH</td><td>yrbrth</td><td>Year of birth</td></tr>
<tr>
<td> 32</td><td> 3</td><td>PLC_BRTH</td><td>plcbrth</td><td>Place of birth</td></tr>
<tr>
<td> 35</td><td> 2</td><td>SEQ_NUM</td><td>seqnum</td><td>Sequence number</td></tr>
<tr>
<td> 37</td><td> 2</td><td>DATE_mo</td><td>modx</td><td>Month of diagnosis</td></tr>
<tr>
<td> 39</td><td> 4</td><td>DATE_yr</td><td>yrdx</td><td>Year of diagnosis</td></tr>
<tr>
<td> 43</td><td> 4</td><td>SITEO2V</td><td>siteo2</td><td>Primary site ICD-O-2 (1973+)</td></tr>
<tr>
<td> 47</td><td> 1</td><td>LATERAL</td><td>lateral</td><td>Laterality</td></tr>
<tr>
<td> 48</td><td> 4</td><td>HISTO2V</td><td>histo2</td><td>Histologic Type ICD-O-2</td></tr>
<tr>
<td> 52</td><td> 1</td><td>BEHO2V</td><td>beho2</td><td>Behavior Code ICD-O-2</td></tr>
<tr>
<td> 53</td><td> 4</td><td>HISTO3V</td><td>histo3</td><td>Histologic Type ICD-O-3</td></tr>
<tr>
<td> 57</td><td> 1</td><td>BEHO3V</td><td>beho3</td><td>Behavior code ICD-O-3</td></tr>
<tr>
<td> 58</td><td> 1</td><td>GRADE</td><td>grade</td><td>Grade</td></tr>
<tr>
<td> 59</td><td> 1</td><td>DX_CONF</td><td>dxconf</td><td>Diagnostic confirmation</td></tr>
<tr>
<td> 60</td><td> 1</td><td>REPT_SRC</td><td>reptsrc</td><td>Type of reporting source</td></tr>
<tr>
<td> 61</td><td> 3</td><td>EOD10_SZ</td><td>eod10sz</td><td>EOD 10 - size (1988+)</td></tr>
<tr>
<td> 64</td><td> 2</td><td>EOD10_EX</td><td>eod10ex</td><td>EOD 10 - extension</td></tr>
<tr>
<td> 66</td><td> 2</td><td>EOD10_PE</td><td>eod10pe</td><td>EOD 10 - path extension</td></tr>
<tr>
<td> 68</td><td> 1</td><td>EOD10_ND</td><td>eod10nd</td><td>EOD 10 - lymph node</td></tr>
<tr>
<td> 69</td><td> 2</td><td>EOD10_PN</td><td>eod10pn</td><td>EOD 10 - positive lymph nodes examined</td></tr>
<tr>
<td> 71</td><td> 2</td><td>EOD10_NE</td><td>eod10ne</td><td>EOD 10 - number of lymph nodes examined</td></tr>
<tr>
<td> 73</td><td>13</td><td>EOD13</td><td>eod13</td><td>EOD--old 13 digit</td></tr>
<tr>
<td> 86</td><td> 2</td><td>EOD2</td><td>eod2</td><td>EOD--old 2 digit</td></tr>
<tr>
<td> 88</td><td> 4</td><td>EOD4</td><td>eod4</td><td>EOD--old 4 digit</td></tr>
<tr>
<td> 92</td><td> 1</td><td>EODCODE</td><td>eodcode</td><td>Coding system for EOD</td></tr>
<tr>
<td> 93</td><td> 1</td><td>TUMOR_1V</td><td>tumor1</td><td>Tumor marker 1</td></tr>
<tr>
<td> 94</td><td> 1</td><td>TUMOR_2V</td><td>tumor2</td><td>Tumor marker 2</td></tr>
<tr>
<td> 95</td><td> 1</td><td>TUMOR_3V</td><td>tumor3</td><td>Tumor marker 3</td></tr>
<tr>
<td> 96</td><td> 3</td><td>CS_SIZE</td><td>cssize</td><td>Collaborative Stage (CS) Tumor Size</td></tr>
<tr>
<td> 99</td><td> 3</td><td>CS_EXT</td><td>csext</td><td>CS Extension</td></tr>
<tr>
<td>102</td><td> 3</td><td>CS_NODE</td><td>csnode</td><td>CS Lymph Nodes</td></tr>
<tr>
<td>105</td><td> 2</td><td>CS_METS</td><td>csmets</td><td>CS Mets at DX</td></tr>
<tr>
<td>107</td><td> 3</td><td>CS_SSF1</td><td>csssf1</td><td>CS Site-Specific Factor 1</td></tr>
<tr>
<td>110</td><td> 3</td><td>CS_SSF2</td><td>csssf2</td><td>CS Site-Specific Factor 2</td></tr>
<tr>
<td>113</td><td> 3</td><td>CS_SSF3</td><td>csssf3</td><td>CS Site-Specific Factor 3</td></tr>
<tr>
<td>116</td><td> 3</td><td>CS_SSF4</td><td>csssf4</td><td>CS Site-Specific Factor 4</td></tr>
<tr>
<td>119</td><td> 3</td><td>CS_SSF5</td><td>csssf5</td><td>CS Site-Specific Factor 5</td></tr>
<tr>
<td>122</td><td> 3</td><td>CS_SSF6</td><td>csssf6</td><td>CS Site-Specific Factor 6</td></tr>
<tr>
<td>125</td><td> 3</td><td>CS_SSF25</td><td>csssf25</td><td>CS Site-Specific Factor 25</td></tr>
<tr>
<td>128</td><td> 2</td><td>D_AJCC_T</td><td>dajcct</td><td>Derived AJCC T</td></tr>
<tr>
<td>130</td><td> 2</td><td>D_AJCC_N</td><td>dajccn</td><td>Derived AJCC N</td></tr>
<tr>
<td>132</td><td> 2</td><td>D_AJCC_M</td><td>dajccm</td><td>Derived AJCC M</td></tr>
<tr>
<td>134</td><td> 2</td><td>D_AJCC_S</td><td>dajccs</td><td>Derived AJCC Stage Group</td></tr>
<tr>
<td>136</td><td> 1</td><td>D_SSG77</td><td>dssg77</td><td>Derived SS1977</td></tr>
<tr>
<td>137</td><td> 1</td><td>D_SSG00</td><td>dssg00</td><td>Derived SS2000</td></tr>
<tr>
<td>138</td><td> 1</td><td>D_AJCC_F</td><td>dajccf</td><td>Derived AJCC - flag</td></tr>
<tr>
<td>139</td><td> 1</td><td>D_SSG77F</td><td>dssg77f</td><td>Derived SS1977 - flag</td></tr>
<tr>
<td>140</td><td> 1</td><td>D_SSG00F</td><td>dssg00f</td><td>Derived SS2000 - flag</td></tr>
<tr>
<td>141</td><td> 6</td><td>CSV_ORG</td><td>csvorg</td><td>CS Version Input Original</td></tr>
<tr>
<td>147</td><td> 6</td><td>CSV_DER</td><td>csvder</td><td>CS Version Derived</td></tr>
<tr>
<td>153</td><td> 6</td><td>CSV_CUR</td><td>csvcur</td><td>CS Version Input Current</td></tr>
<tr>
<td>159</td><td> 2</td><td>SURGPRIM</td><td>surgprim</td><td>RX Summ--surg prim site</td></tr>
<tr>
<td>161</td><td> 1</td><td>SCOPE</td><td>scope</td><td>RX Summ--scope reg LN sur 2003+</td></tr>
<tr>
<td>162</td><td> 1</td><td>SURGOTH</td><td>surgoth</td><td>RX Summ--surg oth reg/dis</td></tr>
<tr>
<td>163</td><td> 2</td><td>SURGNODE</td><td>surgnode</td><td>Number of lymph nodes</td></tr>
<tr>
<td>165</td><td> 1</td><td>RECONST</td><td>reconst</td><td>Reconstruction</td></tr>
<tr>
<td>166</td><td> 1</td><td>NO_SURG</td><td>nosurg</td><td>Reason no cancer-directed surgery</td></tr>
<tr>
<td>167</td><td> 1</td><td>RADIATN</td><td>radiatn</td><td>Radiation</td></tr>
<tr>
<td>168</td><td> 1</td><td>RAD_BRN</td><td>radbrn</td><td>Radiation to Brain and/or CNS</td></tr>
<tr>
<td>169</td><td> 1</td><td>RAD_SURG</td><td>radsurg</td><td>Radiation sequence with surgery</td></tr>
<tr>
<td>170</td><td> 2</td><td>SS_SURG</td><td>sssurg</td><td>Site specific surgery (1983-1997)</td></tr>
<tr>
<td>172</td><td> 2</td><td>SRPRIM02</td><td>srprim02</td><td>Surgery to Primary Site</td></tr>
<tr>
<td>174</td><td> 1</td><td>SCOPE02</td><td>scope02</td><td>Scope of lymph node surgery 98-02</td></tr>
<tr>
<td>175</td><td> 1</td><td>SRGOTH02</td><td>srgoth02</td><td>Surgery to other sites</td></tr>
<tr>
<td>176</td><td> 2</td><td>REC_NO</td><td>recno</td><td>Record number</td></tr>
<tr>
<td>178</td><td> 1</td><td>O_SITAGE</td><td>ositage</td><td>Age-site edit override</td></tr>
<tr>
<td>179</td><td> 1</td><td>O_SEQCON</td><td>oseqcon</td><td>Sequence number-dx conf override</td></tr>
<tr>
<td>180</td><td> 1</td><td>O_SEQLAT</td><td>oseqlat</td><td>Site-type-lat-seq override</td></tr>
<tr>
<td>181</td><td> 1</td><td>O_SURCON</td><td>osurcon</td><td>Surgery-diagnostic conf override</td></tr>
<tr>
<td>182</td><td> 1</td><td>O_SITTYP</td><td>osittyp</td><td>Site-type edit override</td></tr>
<tr>
<td>183</td><td> 1</td><td>H_BENIGN</td><td>hbenign</td><td>Histology edit override</td></tr>
<tr>
<td>184</td><td> 1</td><td>O_RPTSRC</td><td>orptsrc</td><td>Report source sequence override</td></tr>
<tr>
<td>185</td><td> 1</td><td>O_DFSITE</td><td>odfsite</td><td>Seq-ill-defined site override</td></tr>
<tr>
<td>186</td><td> 1</td><td>O_LEUKDX</td><td>oleukdx</td><td>Leuk-Lymph dx confirmation override</td></tr>
<tr>
<td>187</td><td> 1</td><td>O_SITBEH</td><td>ositbeh</td><td>Site-behavior override</td></tr>
<tr>
<td>188</td><td> 1</td><td>O_EODDT</td><td>oeoddt</td><td>Site-EOD-dx date override</td></tr>
<tr>
<td>189</td><td> 1</td><td>O_SITEOD</td><td>ositeod</td><td>Site-laterality-EOD override</td></tr>
<tr>
<td>190</td><td> 1</td><td>O_SITMOR</td><td>ositmor</td><td>Site-laterality-morph override</td></tr>
<tr>
<td>191</td><td> 1</td><td>TYPEFUP</td><td>typefup</td><td>Type of followup expected</td></tr>
<tr>
<td>192</td><td> 2</td><td>AGE_REC</td><td>agerec</td><td>Age recode</td></tr>
<tr>
<td>194</td><td> 5</td><td>SITE_REC</td><td>siterec</td><td>Site recode</td></tr>
<tr>
<td>199</td><td> 5</td><td>SITE2_RE</td><td>site2re</td><td>Site rec with Kaposis and mesothelioma</td></tr>
<tr>
<td>204</td><td> 4</td><td>ICDOTO9V</td><td>ICD9</td><td>Recode ICD-O-2 to 9</td></tr>
<tr>
<td>208</td><td> 4</td><td>ICDOT10V</td><td>ICD10</td><td>Recode ICD-O-2 to 10</td></tr>
<tr>
<td>212</td><td> 3</td><td>ICCCSITE</td><td>icccsite</td><td>ICCC site recode</td></tr>
<tr>
<td>215</td><td> 3</td><td>ICCCSM</td><td>icccsm</td><td>SEER modified ICCC site recode</td></tr>
<tr>
<td>218</td><td> 3</td><td>ICCC3</td><td>iccc3</td><td>ICCC ICD-O-3 Recode</td></tr>
<tr>
<td>221</td><td> 3</td><td>ICCC3EXT</td><td>iccc3ext</td><td>ICCC ICD-O-3 Extended Recode</td></tr>
<tr>
<td>224</td><td> 1</td><td>BEHANAL</td><td>behanal</td><td>Behavior recode for analysis</td></tr>
<tr>
<td>226</td><td> 2</td><td>HISTREC</td><td>histrec</td><td>Broad Histology recode</td></tr>
<tr>
<td>228</td><td> 2</td><td>BRAINREC</td><td>brainrec</td><td>Brain recode</td></tr>
<tr>
<td>230</td><td> 3</td><td>cs0203schema</td><td>cssO3</td><td>Collaborative Stage (CS) Schema v0203</td></tr>
<tr>
<td>233</td><td> 1</td><td>RAC_RECA</td><td>racreca</td><td>Race recode A</td></tr>
<tr>
<td>234</td><td> 1</td><td>RAC_RECY</td><td>racrecy</td><td>Race recode Y</td></tr>
<tr>
<td>235</td><td> 1</td><td>NHIAREC</td><td>nhiarec</td><td>Origin Recode NHIA</td></tr>
<tr>
<td>236</td><td> 1</td><td>HST_STGA</td><td>hststga</td><td>SEER historic stage A</td></tr>
<tr>
<td>237</td><td> 2</td><td>AJCC_STG</td><td>ajccstg</td><td>AJCC stage 3rd edition (1988+)</td></tr>
<tr>
<td>239</td><td> 2</td><td>AJ_3SEER</td><td>aj3seer</td><td>SEER modified AJCC stage 3rd ed (1988+)</td></tr>
<tr>
<td>241</td><td> 1</td><td>SSG77</td><td>ssg77</td><td>SEER Summary Stage 1977 (1995-2000)</td></tr>
<tr>
<td>242</td><td> 1</td><td>SSG2000</td><td>ssg2000</td><td>SEER Summary Stage 2000 2000 (2001-2003)</td></tr>
<tr>
<td>243</td><td> 2</td><td>NUMPRIMS</td><td>numprims</td><td>Number of primaries</td></tr>
<tr>
<td>245</td><td> 1</td><td>FIRSTPRM</td><td>firstprm</td><td>First malignant primary indicator</td></tr>
<tr>
<td>246</td><td> 5</td><td>STCOUNTY</td><td>stcounty</td><td>State-county recode</td></tr>
<tr>
<td>251</td><td> 4</td><td>SURV_TM</td><td>survtm</td><td>Survival time recode</td></tr>
<tr>
<td>255</td><td> 5</td><td>ICD_5DIG</td><td>COD</td><td>Cause of death to SEER site recode</td></tr>
<tr>
<td>260</td><td> 5</td><td>CODKM</td><td>codkm</td><td>COD to site rec KM</td></tr>
<tr>
<td>265</td><td> 1</td><td>STAT_REC</td><td>statrec</td><td>Vital status recode (study cutoff used)</td></tr>
<tr>
<td>266</td><td> 1</td><td>IHS</td><td>ihs</td><td>IHS link</td></tr>
<tr>
<td>267</td><td> 1</td><td>hist_ssg_2000</td><td>histssg2000</td><td>Historic SSG 2000 Stage</td></tr>
<tr>
<td>268</td><td> 2</td><td>AYA_recode</td><td>ayarecode</td><td>AYA recode</td></tr>
<tr>
<td>270</td><td> 2</td><td>Lymphoma_recode</td><td>lymphomarecode</td><td>Lymphoma recode</td></tr>
<tr>
<td>272</td><td> 1</td><td>dth_class</td><td>dthclass</td><td>SEER cause of death classification</td></tr>
<tr>
<td>273</td><td> 1</td><td>o_dth_class</td><td>odthclass</td><td>SEER other cause of death classification</td></tr>
<tr>
<td>274</td><td> 1</td><td>exteval</td><td>exteval</td><td>CS EXT/Size Eval</td></tr>
<tr>
<td>275</td><td> 1</td><td>nodeeval</td><td>nodeeval</td><td>CS Nodes Eval</td></tr>
<tr>
<td>276</td><td> 1</td><td>metseval</td><td>metseval</td><td>CS Mets Eval</td></tr>
<tr>
<td>277</td><td> 1</td><td>intprim</td><td>intprim</td><td>Primary by International Rules</td></tr>
<tr>
<td>278</td><td> 1</td><td>erstatus</td><td>erstatus</td><td>ER Status Recode Breast Cancer (1990+)</td></tr>
<tr>
<td>279</td><td> 1</td><td>prstatus</td><td>prstatus</td><td>PR Status Recode Breast Cancer (1990+)</td></tr>
<tr>
<td>280</td><td> 2</td><td>csschema</td><td>csschema</td><td>CS Schema - AJCC 6th Edition</td></tr>
<tr>
<td>282</td><td> 3</td><td>CS_SSF8</td><td>csssf8</td><td>Cs Site-specific Factor 8</td></tr>
<tr>
<td>285</td><td> 3</td><td>CS_SSF10</td><td>csssf10</td><td>CS Site-Specific Factor 10</td></tr>
<tr>
<td>288</td><td> 3</td><td>CS_SSF11</td><td>csssf11</td><td>CS Site-Specific Factor 11</td></tr>
<tr>
<td>291</td><td> 3</td><td>CS_SSF13</td><td>csssf13</td><td>CS Site-Specific Factor 13</td></tr>
<tr>
<td>294</td><td> 3</td><td>CS_SSF15</td><td>csssf15</td><td>CS Site-Specific Factor 15</td></tr>
<tr>
<td>297</td><td> 3</td><td>CS_SSF16</td><td>csssf16</td><td>CS Site-Specific Factor 16</td></tr>
<tr>
<td>300</td><td> 1</td><td>VASINV</td><td>vasin</td><td>Lymph-vascular Invasion (2004+)</td></tr>
</table>

<br/><br/><font size="-2">(Page generated on Tue May 29 16:36:03 2012 by <a href="http://www.embl.de/~gpau/hwriter/index.html">hwriter</a> 1.3)</font><br/>
</body></html>